Unlike that seen for LDHA, metastatic cancers usually show reduced LDHB expression due to promoter hypermethylation or altered glycolytic signaling; low LDHB levels have been associated with poor prognosis in different cancers (reviewed in [25]). Here, LDHA is linked to cancer.